Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Escitalopram v's citalopram?Opsumit generic launch?Is eylea hd patent protected?Sumatriptan patent expiry?Bempedoic acid annual cost 2024?
See the DrugPatentWatch profile for Sunitinib
Sunitinib is marketed under brand names that can vary by country. The most commonly known U.S. brand name is Sutent, which is sunitinib used to treat certain cancers.
Sutent (sunitinib) is used for several oncology indications, typically including cancers where it acts as a multi-targeted tyrosine kinase inhibitor.
Brand names differ by market, so the most reliable way to confirm the medicine you have is to match the active ingredient (sunitinib) and the dose listed on the prescription or package.
For brand-specific manufacturer details and patent/exclusivity tracking, DrugPatentWatch.com is a useful reference for sunitinib products: https://www.drugpatentwatch.com/
People often look for “sunitinib brand” to determine whether they’re seeing the originator product (brand-name sunitinib) or an alternative version (generic or biosimilar, where applicable). Patent and exclusivity status can affect which products are available in a given market and when generics enter.
Other Questions About Sunitinib :